Pvg Asset Management Corp Chimerix Inc Transaction History

Pvg Asset Management Corp

  • $23.4 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023
SELL
$1.1 - $1.54 $44,984 - $62,978
-40,895 Reduced 58.8%
28,655 $34,000
Q1 2023

Jul 24, 2023
BUY
$1.19 - $2.09 $53,044 - $93,161
44,575 Added 178.48%
69,550 $87,000
Q4 2022

Feb 14, 2023
BUY
$1.67 - $2.35 $41,708 - $58,691
24,975 New
24,975 $46,000
Q3 2022

Oct 13, 2022
SELL
$1.81 - $2.76 $63,549 - $96,903
-35,110 Closed
0 $0
Q4 2021

Feb 02, 2022
BUY
$5.23 - $7.18 $183,625 - $252,089
35,110 New
35,110 $225,000

Others Institutions Holding CMRX

# of Institutions
81
Shares Held
36.8M
Call Options Held
72.2K
Put Options Held
169K
View Full List

About CHIMERIX INC

CMRX Quotes by TradingView
  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Pvg Asset Management Corp Portfolio

Follow Pvg Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pvg Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Pvg Asset Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email